HEAVY-WATER ENHANCES THE ANTINEOPLASTIC EFFECT OF 5-FLUORO-URACIL AND BLEOMYCIN IN NUDE-MICE BEARING HUMAN CARCINOMA

被引:16
作者
ALTERMATT, HJ
GEBBERS, JO
LAISSUE, JA
机构
[1] UNIV BERN,INST PATHOL,FREIBURGSTR 30,CH-3010 BERN,SWITZERLAND
[2] KANTONSSPITAL,INST PATHOL,CH-6000 LUCERNE,SWITZERLAND
关键词
D O I
10.1002/ijc.2910450317
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The antineoplastic effect of heavy water on the growth of xenotransplanted human carcinoma was compared to that of 2 cytostatic drugs. Seven‐week‐old BALB/c‐nu/nu mice were inoculated subcutaneously with a poorly differentiated oropharyngeal squamous‐cell carcinoma, or with variants of carcinoma of the large intestine. After tumor inoculation, 3 subgroups of mice were treated by: (i) moderately deuterated drinking water; (ii) i.p. injections of 5‐Fluoro‐uracil (5‐FU) or Bleomycin; (iii) a combination of deuterated drinking water and of the cytostatic drugs. Control mice were not treated. Heavy water delayed growth of all carcinoma variants. The cytostatic drugs slowed down the growth of the 2 poorly differentiated tumor variants. Conversely, 5‐FU did not retard the growth of the moderately well differentiated colon carcinoma. Heavy water combined with either cytostatic drug showed synergistic effects in the 2 poorly differentiated tumor variants. The tumors of treated animals weighed 36% to 90% less than those of control animals. The antineoplastic effects were more conspicuous in poorly than in moderately well differentiated tumor variants. Cytokinetic parameters such as labelling indices following application of 5‐125I‐Iodo‐2′deoxyuridine, and of Ki‐67, a monoclonal antibody (MAb) directed against an antigen of proliferating cells, or mitotic indices and tumor volume doubling time, combined with the results of histologic evaluation of the tumors, suggested an underlying deuterium‐induced prolongation of tumor‐cell cycle times and a reduction of the growth fraction. Copyright © 1990 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:475 / 480
页数:6
相关论文
共 45 条
  • [1] ADAMS WH, 1988, J PHARMACOL EXP THER, V244, P633
  • [2] ALTERMATT HJ, 1988, CANCER, V62, P462
  • [3] ALTERMATT HJ, 1987, IMMUNE DEFICIENT ANI, P405
  • [4] BARBOUR H. G., 1938, American Journal of Cancer, V32, P440
  • [5] BIGGS MW, 1963, CANCER RES, V23, P1059
  • [6] STUDIES ON LIVER REGENERATION .1. 131IODODEOXYURIDINE AS A PRECURSOR OF DNA IN NORMAL AND REGENERATING RAT LIVER
    BURKI, K
    SCHAER, JC
    GRIEDER, A
    SCHINDLER, R
    COTTIER, H
    [J]. CELL AND TISSUE KINETICS, 1971, 4 (06): : 519 - +
  • [7] CHABNER BA, 1981, CANCER CHEMOTHERAPY, V3, P12
  • [8] FINKEL AJ, 1973, 1ST P INT C STABL IS, P187
  • [9] FINN C, 1975, CANCER CHEMOTH REP 1, V59, P279
  • [10] FRENCH SW, 1961, LAB INVEST, V10, P865